PharmaCorp Rx

PharmaCorp Rx Cost of Goods Sold

The Cost of Goods Sold (COGS) of PharmaCorp Rx (PCRX.V) as of Oct 27, 2026 is 12.60 M CAD. In the previous year, Cost of Goods Sold (COGS) was 3.61 M CAD — a change of 248.87% (higher).

Cost of Goods Sold

12.60 MCAD

YoY

248.87%

Last updated:

Cost of Goods Sold (COGS) of PharmaCorp Rx is 2025 12.60 M CAD. Cost of Goods Sold (COGS) of PharmaCorp Rx was 2024 3.61 M CAD. It decreases by 248.87% higher compared to the previous year.

The PharmaCorp Rx Cost of Goods Sold history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cost of Goods Sold
Date
Cost of Goods Sold
Jan 1, 2023
0.00 CAD
Jan 1, 2024
3.61 M CAD
Jan 1, 2025
12.60 M CAD
The PharmaCorp Rx Cost of Goods Sold history
YEARCost of Goods SoldYoY
12.60 MCAD+248.87%
3.61 MCAD—
0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PharmaCorp Rx Stock analysis

What does PharmaCorp Rx do? Proton Capital Corp. identifies and evaluates potential assets or businesses for a qualifying transaction. The company has not selected a specific sector or industry for its future operations. It has no commercial operations and no assets as of now. The firm is structured as a capital pool company aiming to complete a qualifying transaction in the future. The company's primary focus is on identifying and evaluating assets or businesses without specifying a target sector. It has not commenced commercial operations and has no assets. Proton Capital Corp. operates as a capital pool company with the intention of completing a qualifying transaction in the future. Proton Capital Corp. has not selected a business sector or industry for its qualifying transaction. The firm remains in a pre-commercial phase with no assets or operations. It is structured as a capital pool company that will seek to complete a qualifying transaction once a suitable target is identified. PharmaCorp Rx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCorp Rx stock

Cost of Goods Sold (COGS) of PharmaCorp Rx is 12.60 M CAD in 2025.

Cost of Goods Sold (COGS) of PharmaCorp Rx changed from 3.61 M CAD to 12.60 M CAD, representing a 248.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cost of Goods Sold (COGS) PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

COGS represents the direct costs attributable to the production of goods sold. It includes material and labor costs directly tied to the product.

Cost of Goods Sold (COGS)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cost of Goods Sold (COGS)'s PharmaCorp Rx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — PharmaCorp Rx

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PharmaCorp Rx